METASTATIC HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Clinical trials for METASTATIC HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test novel drug duo in fight against Tough-to-Treat cancers
Disease control Recruiting nowThis early-phase study aims to find a safe and tolerable dose of a new drug combination for people with advanced breast cancer and other solid tumors that have a protein called HER2. The trial will test pidnarulex, which aims to stop tumor cell growth, together with an existing t…
Matched conditions: METASTATIC HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Custom-Made vaccine trial launches for Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing the safety of a personalized vaccine designed to train a patient's immune system to attack their specific cancer. It is for adults with advanced breast cancer, melanoma, or non-small cell lung cancer that has continued to grow despite standard tr…
Matched conditions: METASTATIC HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New vaccine aims to train immune system to fight spreading breast cancer
Disease control Recruiting nowThis study is testing whether a vaccine called STEMVAC can help control advanced breast cancer that has spread. The vaccine is designed to boost the immune system to recognize and attack cancer cells. It's being given alongside standard hormone therapies or chemotherapy to 40 pat…
Matched conditions: METASTATIC HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New scan could tell doctors which breast cancer drugs will work
Knowledge-focused Recruiting nowThis study is testing whether a special type of PET scan can predict if a breast cancer drug called abemaciclib will work for patients with advanced hormone-positive, HER2-negative breast cancer. Researchers will give 60 participants this special scan before and after a brief hor…
Matched conditions: METASTATIC HORMONE RECEPTOR-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC